Enanta Pharmaceuticals (ENTA) Current Deferred Tax Assets (2014 - 2016)

Enanta Pharmaceuticals (ENTA) has 3 years of Current Deferred Tax Assets data on file, last reported at $1.1 million in Q2 2016.

• Quarterly Current Deferred Tax Assets fell 34.72% year-over-year to $1.1 million in Q2 2016, while the trailing twelve-month figure through Jun 2016 was $1.1 million (down 34.72% YoY) and the FY2015 annual result came in at $1.4 million, down 86.99% from the prior year.
• Current Deferred Tax Assets slipped to $1.1 million in Q2 2016, from $1.6 million in the prior quarter.
• In the past five years, Current Deferred Tax Assets ranged from a high of $11.2 million in Q2 2014 to a low of $1.1 million in Q2 2016.
• A 3-year average of $3.6 million and a median of $1.6 million in 2015 frame the typical range for Current Deferred Tax Assets.
• The widest YoY moves for Current Deferred Tax Assets: up 17.28% in 2015, down 86.99% in 2015.
• Tracing ENTA's Current Deferred Tax Assets over 3 years: stood at $1.3 million in 2014, then gained by 17.28% to $1.6 million in 2015, then dropped by 27.45% to $1.1 million in 2016.
• The last three Current Deferred Tax Assets figures came in at $1.1 million (Q2 2016), $1.6 million (Q1 2016), and $1.6 million (Q4 2015), per Business Quant data.